| Phone |
| |
| |
| 대표전화 |
1577-7956 |
| 본 사 |
031-457-9187 |
| 대 전 |
042-932-1265 |
| |
|
| Web Site Visitors |
| |
| |
| Today |
575 |
| Yesterday |
1655 |
| Since 2006 |
2,702,941 |
| |
|
|
|
 Industry : |
| |
Pharmaceutical |
| | |
| Product : |
| |
Drug nanosuspension |
| | |
| Test Objective : |
| |
Solvent / antisolvent crystallization |
| | |
| Reactants : |
| |
Drug solution and water - reactant streams are miscible |
| | |
| Processor : |
| |
Microfluidics reactors (Microfluidizer High Shear Processor 장비보기) |
| | |
| Chambers : |
| |
Interaction Chamber (upstream) F20Y (75 um)
Auxiliary Processing Module (downstream) H30Z (200 um) |
| | |
| Number of passes : |
| |
1 - 3 |
| | |
| Median particle size : |
| |
D50 = 480 nm |
| | |
| Process pressure : |
| |
12,000 psi |
| | |
| Summary of results : |
| |
As a drug solution interacted with an anti-solvent, the drug precipitated in the form of nanocrystals.
(pdf 화일 다운로드) |
| | |
| | |
| | |
| |
|
| | |
|
|
|
